Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02281149 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:

Study acronym: TOMOBREAST
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 3 words
  2. Study completion date: Dec 31, 2025 to Mar 31, 2026v10
  3. 2 versions Re-verified since Jul 19, 2022, no change to tracked fieldsv8-v9
  4. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 300 to confirmed 500
    • Site details revised at 2 of 2 sites
    v7
  5. Primary completion date: Nov 2019 to Dec 31, 2022
    • Study completion date: Nov 2024 to Dec 31, 2025
    • Start date: Nov 2014 to Nov 18, 2014
    • Site details revised at 2 of 2 sites
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 1 to 2
    • Primary completion date: Nov 2020 to Nov 2019
    • Study completion date: Nov 2020 to Nov 2024
    • Secondary endpoints: 3 to 4
    v5
  2. 2 versions Re-verified since Jan 16, 2015, no change to tracked fieldsv3-v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adjuvant radiotherapy after lumpectomy allows a local long-term control of the order 85 to 95% with a survival rate equivalent to that of the totally mastectomy. The diminution of the local recurrence rate after irradiation post- lumpectomy is also associated to a best global survival than only the surgery. The adjuvant radiotherapy after partially or totally mastectomy for the progressive tumors is a therapeutic standard (Early Breast Cancer Trialists' Collaborative Group 2011). The aim of our trial of routine care is to record our practices under this breast adjuvant radiotherapy.
Trial Details
NCT Number NCT02281149
Lead Sponsor Centre Oscar Lambret
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov